✦ LIBER ✦

TCT-140 Prospective Multicenter Registry of 6 Months Dual Antiplatelet Therapy after new Generation Drug-eluting Stent Implantation: ESTROFA-DAPT Study.

✍ Scribed by De la Torre Hernandez, Jose M.; Oteo Dominguez, Juan F.; Hernandez, Felipe; Abdul-Jawad Altisent, Omar; Rivero-Crespo, Fernando; Cascon, Jose D.; Arrebola, Antonio L.; Gimeno, Federico; Zavala, German; Andraka, Leire; Gomez Menchero, Antonio; Bosa, Francisco; Carrillo, Xavier; De Lemos, Rocio; Ramirez Moreno, Antonio; Castillo, Jose L.; Sanchez-Recalde, Angel; Tizon-Marcos, Helena

Book ID: 122119280
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 111 KB
Volume: 62
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.08.873

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-488 Risk of stent thrombosis with 6

TCT-488 Risk of stent thrombosis with 6 vs. 12 months dual antiplatelet therapy after new generations drug-eluting stents implantation: final results of the multicenter prospective ESTROFA-DAPT study

✍ De la Torre Hernandez, Jose M.; Oteo Dominguez, Juan F.; Hernandez, Felipe; Cama 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 78 KB

TCT-8 6-month versus 12-month dual antip

TCT-8 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent: Prospective, Randomized, Multicenter Trial

✍ Lee, Byoung Kwon; Bum-Kee, Hong; Yoon, Young Won; Min, Pil-Ki; Kwon, Hyuck Moon; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Reduced antiplatelet therapy after drug-

Reduced antiplatelet therapy after drug-eluting stenting: Multicenter janus flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months—matrix study

✍ Salvatore Cassese; Giuseppe De Luca; Bruno Villari; Sergio Berti; Pietro Bellone 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB

Six-Month Versus 12-Month Dual Antiplate

Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) Randomized, Multicenter Study

✍ Gwon, H.-C.; Hahn, J.-Y.; Park, K. W.; Song, Y. B.; Chae, I.-H.; Lim, D.-S.; Han 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 983 KB

Rationale and design of a randomized, do

Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study

✍ Robert A. Byrne; Stefanie Schulz; Julinda Mehilli; Raisuke Iijima; Steffen Massb 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 183 KB